Buy Denali Therapeutics Stock | DNLI Stock Price & Latest News | Public.com
DNLI

Denali Therapeutics

$0.00 (0.00%)Today
    View Denali Therapeutics (DNLI) stock trends here

    About DNLI

    Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by R...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.37
    -0.56
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.44

    Actual EPS
    Q1 2021

    Stats

    Market Cap$8B
    Volume438,11k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$93.94
    1 Year Low$12.39
    Open$65.76
    High$67.66
    Low$62.20

    Buy any stock with any amount of money.

    Download the App
    Download the app